NCT03410693 2022-09-28
FORT-1
Bayer
Phase 2/3 Completed
Clinical Trials
4 trialsNCT01668459 2018-12-04
CabB1
University Hospital Birmingham NHS Foundation Trust
Phase 2/3 Completed
NCT00406068 2016-07-28
Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer
Bioniche Life Sciences Inc.
Phase 2/3 Completed
NCT00389155 2015-12-07
First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
Bristol-Myers Squibb
Phase 2/3 Completed